Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti ☰
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Aspergillosi

Bibliografia

Quali fonti bibliografiche considerare per l' Aspergillosi?

Le informazioni contenute nella ricerca Pharmamedix dedicata all’aspergillosi sono state analizzate con riferimento alle seguenti fonti.

  1. Abbaszadeh S. et al., J. Mycol. Med., 2014, 24 (2), e51.

  2. Agarwal R. et al., Eur. Respir. J., 2024, 63 (4), 2400061.

  3. Bassetti M. et al., J. Infect., 2018, 76 (1), 103.

  4. Bassetti M. et al., Intensive Care Med., 2024. 50 (4), 502.

  5. Castro-Fuentes C.A. et al., J. Fungi (Basel), 2026, 12 (3), 229.

  6. Cornely O.A. et al., NEJM, 2007, 356 (4), 348.

  7. Denning D.W., Lancet Infect. Dis., 2024, 24 (7), e428.

  8. Epelbaum O. et al., Am. J. Respir. Crit. Care Med., 2025, 211 (1), 34.

  9. Evans T.J. et al., Semin. Respir. Crit. Care Med., 2024, 45 (1), 88.

  10. Hu X. Et al., Breathe (Sheff), 2024, 20 (3), 230234.

  11. Khan M.S.A., Ahmad I., Phytomedicine, 2011, 19 (1), 48.

  12. Lamoth F. et al., Mycoses, 2025, 68 (11), e70132.

  13. Maertens J.A. et al., Lancet, 2016, 387 (10020), 760.

  14. Maertens J.A. et al., Lancet, 2021, 397 (10273), 499.

  15. Masci Walter, Omeopatia - Tradizione e attualità, 2003, Tecniche Nuove.

  16. Pagano L. et al., Leukemia, 2025, 39 (7), 1547.

  17. Patterson T.F. et al., Cli. Infect. Dis., 2016, 63 (4), e1.

  18. Puglia D.R. et al., Clin. Pract., 2024, 14 (1), 280.

  19. Saine A., Am. J. Homeopathic Med., 2017, 110 (3), 32.

  20. Sharma M. et al., Homœopathic Links, 2025, 38 (2), 85.

  21. Schuster M.G. et al., IDSA 2026 Clinical Practice Guideline Update on the Prevention of Invasive Aspergillosis in Adult Solid organ Transplant Recipients, 2026, July 06 https://www.idsociety.org/practice-guideline/2026-idsa-clinical-practice-guidelines-on-prevention-of-invasive-aspergillosis-in-adult-solid-organ-transplant-recipients (accesso: novembre 2026).

  22. Tan L.F. et al., Plants (Basel), 2022, 11 (22), 3009.

  23. Tashiro M. et al., Ther. Adv. Infect. Dis., 2024, 11, 20499361241253751.

  24. Ullmann A.J. et al., NEJM, 2007, 356 (4), 335.

  25. U.S. Centers for Disease Control and Prevention – CDC, Aspergillosi – Reducing Risk for Aspergillosis, 2026, october 5 www.cdc.gov/aspergillosis/prevention/index.html (accesso: novembre 2026).

  26. Wichmann D. et al., Infection, 2025, 53 (4), 1299.

  27. World Health Organisation - WHO, 1993, Research guidelines for evaluating the safety and efficacy of herbal medicines.

 

;